Perhaps 2024 will one day be seen as a turning point in psychiatry’s long-term project to drug as many of the population as possible. In 2022, a group headed by Joanna Moncrieff in London published a study on the role of disturbances of the neurotransmitter, 5-HT or serotonin, in depression. They concluded:
The main areas of serotonin research provide no…
Keep reading with a 7-day free trial
Subscribe to Niall McLaren on Critical Psychiatry to keep reading this post and get 7 days of free access to the full post archives.